Clinical Trial Update: BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of buparlisib (BKM120) combined with the mFOLFOX6 regimen in patients with advanced solid tumors completed, including an expansion cohort in met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• BKM120 (Buparlisib) (buparlisib)
• mFOLFOX6 regimen

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Advanced Solid Tumors, Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED